Risks tied to this specific entity.
No issues detected across 7 sources
No issues detected across 1 source
International Paper's spinoff of its EMEA packaging business presents significant competitive and market consolidation implications for DS Smith's European packaging operations and supply chain positioning.
DS Smith's potential closure of its Launceston manufacturing facility poses high supply chain risk through reduced production capacity and potential supply disruptions for customers relying on that operational base.
DS Smith's planned spin-off from US ownership and return to London listing presents medium supply chain risk through potential operational disruption and strategic restructuring during transition.
foodprocessing.com.au: Well - rounded solution for Carlsberg beer bottles; zfenglish.com: DS Smith Retools Timisoara Plant via EUR10 . 5M Investmen...; finance.yahoo.com: DS Smith and Absolut Vodka introduce recyclable brown box...
GDELTNo issues detected across 2 sources
Top origins: Netherlands, Spain, France. Period: 2023-05-01 to 2026-05-01
ImportYeti (US Customs)No issues detected across 1 source
Risks tied to the location of this facility.
Political stability: 0.51, Rule of law: 1.4, Corruption control: 1.48
World Bank WGI 2023No issues detected across 2 sources
A significant meningococcal disease outbreak in Kent, England could disrupt DS Smith's UK workforce through employee illness, absenteeism, and facility closures, potentially affecting manufacturing and distribution operations in the affected region.
Meningococcal disease outbreak in the UK could disrupt DS Smith's workforce through employee absences, illness, or preventive measures, potentially affecting packaging manufacturing operations, though the disease does not directly impact raw materials or product safety.
Meningococcal disease outbreak could disrupt DS Smith's UK workforce through employee illness, absenteeism, and potential facility closures, impacting manufacturing and delivery operations, though the alert notes low risk to the wider population.
A meningococcal outbreak in the UK could disrupt DS Smith's workforce through employee illness, absenteeism, and facility closures, potentially affecting packaging manufacturing operations in affected regions.
Meningitis outbreaks at UK universities could disrupt DS Smith's workforce through employee illness and absenteeism, particularly if facilities are located near affected areas or employ significant numbers of young workers, though the impact is unlikely to be severe enough to affect supply chain or manufacturing operations directly.
Localized meningococcal outbreak in Kent could disrupt DS Smith's UK workforce through employee absences, facility closures, or public health restrictions, particularly if the company has manufacturing or distribution facilities in the affected region.
Meningococcal disease outbreak in Kent could disrupt DS Smith's UK operations through workforce illness and absenteeism, particularly if facilities are located in or near the affected region, though the disease does not directly affect packaging materials or manufacturing processes.
Measles outbreak in Birmingham could disrupt DS Smith's UK operations through workforce absenteeism and potential facility closures, as the company operates multiple manufacturing sites in the United Kingdom and would be subject to public health containment measures.
A localized meningococcal outbreak in Kent could disrupt DS Smith's UK workforce through employee absences, facility closures, or health precautions if operations are concentrated in the affected region, though packaging manufacturing has no direct product safety connection to this disease.
Localized meningococcal outbreak in Dorset could disrupt DS Smith's UK operations through workforce absenteeism, particularly if facilities are located in or near affected areas, though the targeted vaccination response limits broader supply chain impact.
PROMED alert in United Kingdom: cholera
PROMED alert in United Kingdom: measles
PROMED alert in United Kingdom: meningitis - neisseria
PROMED alert in United Kingdom: meningitis